Glimisave Mv 3.3

Composition

Metformin (500mg) + Voglibose (0.3mg) + Glimepiride (3mg)

Uses of Glimisave Mv 3.3

Glimisave MV 3.3 Tablet SR is used in the treatment of type 2 diabetes.

How it works

Glimisave MV 3.3 Tablet SR is a combination of three antidiabetic medicines: Glimepiride, metformin and voglibose. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas to lower the blood glucose. Metformin is a biguanide which lowers glucose production in the liver, delays glucose absorption from intestines and increases the body's sensitivity to insulin. Voglibose is an alpha-glucosidase inhibitor which prevents breakdown of complex sugars into simple sugars such as glucose. This prevents the blood glucose levels from rising to very high levels after meals.

Directions for use

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimisave MV 3.3 Tablet SR is to be taken with food.Glimisave MV 3.3 Tablet SR may cause stomach upset if taken on empty stomach.

Side effects

Common side effects of Glimisave Mv 3.3 may include:

• •Hypoglycemia (low blood sugar level) Nausea Diarrhea Taste change Flatulence Stomach pain Headache Skin rash Respiratory tract infection

Manufacturer & class

Manufacturer:

ERIS LIFE SCIENCES PVT LTD